Evidence map›Paper›PMID 29270499›Full record

ArticleKidney international reports2017

Feasibility of Incremental 2-Times Weekly Hemodialysis in Incident Patients With Residual Kidney Function.

Andrew I Chin, Suresh Appasamy, Robert J Carey, Niti Madan

Registry-linked trialAbstract read
In one paragraph

Article in Kidney international reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03740048 (A Randomized Pilot Study of Hemodialysis Initiation Comparing Twice-Weekly Hemodialysis Plus Dialysis-Sparing Therapy Versus Thrice-Weekly Hemodialysis), which is not on this map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03740048 phase3completednot on this mapstarted 2019, after this paper: background citation

A Randomized Pilot Study of Hemodialysis Initiation Comparing Twice-Weekly Hemodialysis Plus Dialysis-Sparing Therapy Versus Thrice-Weekly Hemodialysis (The TWOPLUS-HD Trial)

TypeinterventionalSponsorWake Forest University Health SciencesRan2019 to 2021Enrolled51ConditionsEnd Stage Renal Failure on DialysisArmsHemodialysis, Patiromer Oral Product
3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Incremental Hemodialysis: What We Know so Far.International journal of nephrology and renovascular disease · 2022
    Review
  7. Precision medicine in transplantation and hemodialysis.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2021
    Article
  8. Cerebral Perfusion in Hemodialysis Patients: A Feasibility Study.Canadian journal of kidney health and disease · 2021
    Article
  9. Incremental and Twice-Weekly Hemodialysis Program in Practice.Clinical journal of the American Society of Nephrology : CJASN · 2020
    Article
  10. Individualized acute kidney injury after care.Current opinion in critical care · 2020
    Review
  11. Review
  12. Review
  13. Narrative Review of Incremental Hemodialysis.Kidney international reports · 2020
    Review
  14. Article
  15. Article
  16. Article
  17. The Authors Reply.Kidney international reports · 2018
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Andrew I ChinDepartment of Internal Medicine, Division of Nephrology, University of California, Davis School of Medicine, Sacramento, California, USA.
Suresh AppasamyDepartment of Internal Medicine, Division of Nephrology, University of California, Davis School of Medicine, Sacramento, California, USA.
Robert J CareyDepartment of Internal Medicine, Division of Nephrology, University of California, Davis School of Medicine, Sacramento, California, USA.
Niti MadanDepartment of Internal Medicine, Division of Nephrology, University of California, Davis School of Medicine, Sacramento, California, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionWe hypothesized that at least half of incident hemodialysis (HD) patients on 3-times weekly dialysis could safely start on an incremental, 2-times weekly HD schedule if residual kidney function (RKF) had been considered.

methodsRKF is assessed in all our HD patients. This single-center, retrospective cohort study of incident adult HD patients, who survived ≥6 months on a 3-times weekly HD regimen and had a timed urine collection within 3 months of starting HD, assessed each patient's theoretical ability to achieve adequate urea clearance, ultrafiltration rate, and hemodynamic stability if on 2-times weekly HD.

resultsOf the 410 patients in the cohort, we found that 112 (27%) could have optimally and 107 (26%) could have been appropriately considered for 2-times weekly incremental HD. In general, diuretics were underutilized in >50% of subjects who had adequate RKF urea clearance. The optimal 2-times weekly patients had better potassium and phosphorus control. The correlation coefficient of calculated residual kidney urea clearance with 24-hour urine volume and with kinetic model residual kidney clearance was 0.68 and 0.99, respectively. DISCUSSION: More than 50% of incident HD patients with RKF have adequate kidney urea clearance to be considered for 2-times weekly HD. When additionally ultrafiltration volume and blood pressure stability are taken into account, more than one-fourth of the total cohort could optimally start HD in an incremental fashion.

Indexed as

hemodialysisincremental hemodialysisresidual renal function

Identifiers

PMID29270499
PMCPMC5733820

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.